Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Aprepitant Oral Suspension in Adolescents
NCT01249001Phase 2Terminated
- Sponsor
- SickKids
- Start
- Oct 2010
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aprepitant in chemotherapy-induced nausea and vomiting (CINV), sponsored by SickKids. Started Oct 2010; status: terminated.
02
Drugs
aprepitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01249001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01249001.